<DOC>
	<DOCNO>NCT01618058</DOCNO>
	<brief_summary>The purpose trial determine exposure ARV-containing investigational product IPM clinical trial impact natural history HIV infection measure virologic , immunologic clinical outcome participant become HIV-positive IPM 027 trial .</brief_summary>
	<brief_title>Observational Study HIV Infection Participants Seroconvert During Dapivirine Vaginal Ring Trials</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<criteria>Recent HIV seroconversion participation IPM 027 , accord HIV test algorithm trial Ability willingness provide inform consent Willingness give research centre permission share information primary health care provider ( PHCP ) , willingness sign approve sitespecific documentation facilitate sharing . Any condition , opinion Investigator , would preclude provision inform consent , make participation study unsafe , complicate interpretation study outcome data , otherwise interfere achieve study objective .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>HIV Infections</keyword>
	<keyword>Anti-HIV Agents</keyword>
	<keyword>HIV-1</keyword>
</DOC>